Skip to Content

Join the 'BeneFix' group to help and get support from people like you.

BeneFix News

Long-Acting Clotting Agent Alprolix Approved for Form of Hemophilia

Posted 31 Mar 2014 by

MONDAY, March 31, 2014 The drug Alprolix has been approved by the U.S. Food and Drug Administration as the first long-acting hemophilia B clotting agent, the FDA said in a news release. The product, formally known as "coagulation factor IX recombinant Fc Fusion protein" is the first hemophilia B remedy designed to require less frequent injections than prior treatments, the FDA said. It was ...

Ask a Question

Further Information

Related Condition Support Groups

Factor IX Deficiency, Hemophilia B

BeneFix Patient Information at